Touma Z - Search Results

1

Comparison of the Sensitivity to Change of the 36-Item Short Form Health Survey and the Lupus Quality of Life Measure Using Various Definitions of Minimum Clinically Important Differences in Patients With Active Systemic Lupus Erythematosus.

Nantes SG, Strand V, Su J, Touma Z. Nantes SG, et al. Among authors: touma z. Arthritis Care Res (Hoboken). 2018 Jan;70(1):125-133. doi: 10.1002/acr.23240. Epub 2017 Dec 8. Arthritis Care Res (Hoboken). 2018. PMID: 28320078

2

SLEDAI-2K for a 30-day window.

Touma Z, Urowitz MB, Gladman DD. Touma Z, et al. Lupus. 2010 Jan;19(1):49-51. doi: 10.1177/0961203309346505. Epub 2009 Nov 12. Lupus. 2010. PMID: 19910390

3

Burden of autoantibodies and association with disease activity and damage in systemic lupus erythematosus.

Touma Z, Gladman DD, Tulloch-Reid D, Toloza SM, Ibañez D, Fortin PR, Urowitz MB. Touma Z, et al. Clin Exp Rheumatol. 2010 Jul-Aug;28(4):525-31. Epub 2010 Aug 30. Clin Exp Rheumatol. 2010. PMID: 20659409

4

Optimal frequency of visits for patients with systemic lupus erythematosus to measure disease activity over time.

Ibañez D, Gladman DD, Touma Z, Nikpour M, Urowitz MB. Ibañez D, et al. Among authors: touma z. J Rheumatol. 2011 Jan;38(1):60-3. doi: 10.3899/jrheum.100575. Epub 2010 Nov 15. J Rheumatol. 2011. PMID: 21078718

5

Development and initial validation of the systemic lupus erythematosus disease activity index 2000 responder index 50.

Touma Z, Gladman DD, Ibañez D, Urowitz MB. Touma Z, et al. J Rheumatol. 2011 Feb;38(2):275-84. doi: 10.3899/jrheum.100724. Epub 2010 Dec 1. J Rheumatol. 2011. PMID: 21123323

6

Systemic lupus erythematosus disease activity index 2000 responder index-50: a reliable index for measuring improvement in disease activity.

Touma Z, Urowitz MB, Fortin PR, Landolt C, Toloza SM, Riddell C, Chandran V, Eder L, Ghanem A, Ziouzina O, Taghavi-Zadeh S, Ibañez D, Gladman DD. Touma Z, et al. J Rheumatol. 2011 May;38(5):868-73. doi: 10.3899/jrheum.101080. Epub 2011 Feb 15. J Rheumatol. 2011. PMID: 21324961

7

Is there an advantage over SF-36 with a quality of life measure that is specific to systemic lupus erythematosus?

Touma Z, Gladman DD, Ibañez D, Urowitz MB. Touma Z, et al. J Rheumatol. 2011 Sep;38(9):1898-905. doi: 10.3899/jrheum.110007. Epub 2011 Jul 1. J Rheumatol. 2011. PMID: 21724700

8

Systemic Lupus Erythematosus Disease Activity Index 2000 Responder Index-50 enhances the ability of SLE Responder Index to identify responders in clinical trials.

Touma Z, Gladman DD, Ibañez D, Taghavi-Zadeh S, Urowitz MB. Touma Z, et al. J Rheumatol. 2011 Nov;38(11):2395-9. doi: 10.3899/jrheum.110550. Epub 2011 Sep 1. J Rheumatol. 2011. PMID: 21885488

9

Ability of non-fasting and fasting triglycerides to predict coronary artery disease in lupus patients.

Touma Z, Gladman DD, Ibañez D, Urowitz MB. Touma Z, et al. Rheumatology (Oxford). 2012 Mar;51(3):528-34. doi: 10.1093/rheumatology/ker339. Epub 2011 Nov 24. Rheumatology (Oxford). 2012. PMID: 22120460

10

Seasonal variation in vitamin D levels in psoriatic arthritis patients from different latitudes and its association with clinical outcomes.

Touma Z, Eder L, Zisman D, Feld J, Chandran V, Rosen CF, Shen H, Cook RJ, Gladman DD. Touma Z, et al. Arthritis Care Res (Hoboken). 2011 Oct;63(10):1440-7. doi: 10.1002/acr.20530. Arthritis Care Res (Hoboken). 2011. PMID: 22121512 Free article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

180 results

Search Page

Filters